Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with…




Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with…
Investigators identified changes in immune cells that predict patient recovery, pointing to a drug that…


The new effort aims to rapidly transform academic breakthroughs into life-saving therapies for a range…
Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline…


A grant from the National Institutes of Health will help Wayne State University researchers explore…


The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care…